Original articleGeneral thoracicA Prospective Clinical Trial of Telecytopathology for Rapid Interpretation of Specimens Obtained During Endobronchial Ultrasound–Fine Needle Aspiration
Section snippets
Material and Methods
We designed a single-center, prospective nonrandomized trial at Barnes-Jewish Hospital–Washington University in St. Louis School of Medicine. Following Investigational Review Board approval, we identified eligible patients in our patient clinics or from in-hospital consultations. For inclusion in the study, patients must have fulfilled all of the following criteria: mediastinal or nodal pathology, or both, requiring EBUS-FNA for diagnosis or staging, ability to tolerate general anesthesia, age
Results
From May through August 2013, 23 patients were evaluated using the conventional method (control group). The transitional phase was occurred from September through mid-October 2013 and included 17 patients to familiarize the cytology team and operating room staff with the telecytology equipment (Fig 1A and B). These patients were not included in the data analysis. The TCP phase of the study involved an additional 20 patients (TCP group) and was carried out from late October 2013 through the end
Comment
EBUS-FNA has become an important tool for the staging of lung cancer and for the evaluation and diagnosis of other intrathoracic pathology. Institutional practices regarding the evaluation of EBUS-FNA specimens obtained during these procedures vary widely. Pathologic interpretation of the specimens is provided by a cytopathologist and is the preferred method at our institution. This is particularly important if additional procedures are planned based on the biopsy results. This applies not only
References (13)
- et al.
Endobronchial ultrasound-guided fine-needle aspiration of mediastinal lymph nodes: a single institution’s early learning curve
Ann Thorac Surg
(2008) - et al.
Transbronchial and transesophageal fine-needle aspiration using an ultrasound bronchoscope in mediastinal staging of potentially operable lung cancer
Chest
(2010) - et al.
Rapid on-site evaluation of transbronchial aspirates in the diagnosis of hilar and mediastinal adenopathy—a randomized trial
Chest
(2011) - et al.
Impact of rapid on-site cytologic evaluation during transbronchial needle aspiration
Chest
(2005) What does one minute of operating room time cost?
J Clin Anesth
(2010)- et al.
Minimally invasive endoscopic staging of suspected lung cancer
JAMA
(2008)
Cited by (20)
American Society of Cytopathology Telecytology validation recommendations for rapid on-site evaluation (ROSE)
2024, Journal of the American Society of CytopathologyFeatures of teleoncology in lung cancer: A scoping review
2023, Patient Education and CounselingThe 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
2022, Journal of Thoracic OncologyCitation Excerpt :Depending on the local expertise of the physicians (pulmonologists, radiologists, surgeons, cytopathologists) who obtain the specimens, the optimal approach will vary from one institution to another. Confirmation of specimen adequacy at the time of the procedure can be aided by rapid on-site evaluation, including telepathology methods,17–21 although this is not essential. Molecular testing including next-generation sequencing can reveal high diagnostic yield in cytology samples with cell blocks or ethanol-fixed smears or liquid-based preparations.20,22,23
Rapid On-site Evaluation and Final Cytologic Diagnoses Correlation during Endobronchial Ultrasonography
2022, Journal of Bronchology and Interventional Pulmonology